Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?
Listen now
Description
How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out.    Credit available for this activity expires: 03/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462 ?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
Do you really know the optimal biomarker tests for personalizing breast cancer treatment? Are some just unnecessary? Find out from the experts!    Credit available for this activity expires: 4/30/2025 Earn Credit / Learning Objectives & Disclosures:...
Published 04/30/24
Published 04/30/24
Do you know the symptoms that affect more than 80% of people with Alzheimer's disease in some countries?    Credit available for this activity expires: 04/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000723?ecd=bdc_podcast_libsyn_mscpedu
Published 04/29/24